To Recall Or Not To Recall? Pfizer, Merck COX-2 Approaches Mulled
This article was originally published in The Tan Sheet
Executive Summary
The market withdrawal of Merck's Vioxx and Pfizer's actions related to Celebrex present two case studies of how pharmaceutical companies handle drug safety issues that arise with their blockbuster products